Clinical Trial Update: Intraventricular Tissue Plasminogen Activator (tPA) in the Management of Aneurysmal Subarachnoid Hemorrhage [Phase 2]

View source ↗

Summary

This entry summarizes a Phase 2 clinical trial evaluating intraventricular tissue plasminogen activator (tPA) for the management of aneurysmal subarachnoid hemo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage
• Intraventricular Hemorrhage

Drugs mentioned

• Activase (tissue plasminogen activator) (tissue plasminogen activator)

Snippet

Sponsor: University of Calgary | Conditions: Aneurysmal Subarachnoid Hemorrhage, Intraventricular Hemorrhage | Phase 2 | Status: UNKNOWN